home / stock / bway / bway news


BWAY News and Press, BrainsWay Ltd. From 06/09/20

Stock Information

Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com

Menu

BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...

BWAY - BrainsWay to Report First Quarter 2020 Financial Results and Operational Highlights on June 24, 2020

PATTERSON, N.J. and JERUSALEM, Israel, June 09, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it will report its fi...

BWAY - BrainsWay Strengthens Senior Leadership Team with Appointment of Christopher Boyer as Vice President of Global Marketing

PATTERSON, N.J., May 20, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced the appointment of Christopher Boyer as Vice Pre...

BWAY - BrainsWay Enhances Senior Leadership with Promotion and New Executive Addition

Hadar Levy Promoted to Senior Vice President and General Manager of North America Company Appoints Seasoned Medical Technology Finance Professional, Judith Huber, as Senior Vice President and Chief Financial Officer PATTERSON, N.J. and JERUSALEM, May 06, 2020 (GLOBE NEWSWIRE) -- Bra...

BWAY - BrainsWay Launches #StandAgainstTheStigma Campaign to Promote Mental Health Awareness Month

PATTERSON, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd.   (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced the launch of #StandAgainstTheS...

BWAY - BrainsWay guides Q1 revenue below consensus

BrainsWay (NASDAQ: BWAY ) sees Q1 revenue in the range of $3.9M-$4.2M vs. consensus of $4.97M. More news on: Brainsway Ltd., Healthcare stocks news, Read more ...

BWAY - BrainsWay Announces Preliminary Revenue Range for First Quarter of 2020

PATTERSON, N.J., April 13, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced a preliminary, unaudited revenue range for the ...

BWAY - The Remedy Is Now Offering Deep Transcranial Magnetic Stimulation (Deep TMS) Therapy to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

VADNAIS HEIGHTS, Minn., April 07, 2020 (GLOBE NEWSWIRE) -- The Remedy , a person-centered mental health care facility offering advanced treatments, announced today that it is now offering BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) for major depressive disord...

BWAY - Brainsway Continues Growth Trajectory While Conserving Cash

Quick Take Brainsway ( BWAY ) went public in April 2019, raising $28 million in gross proceeds from an IPO. The firm designs and sells non-invasive medical devices to treat psychological disorders. BWAY continues to produce revenue and gross profit growth and has future growth prospects ...

BWAY - Brainsway Ltd. (BWAY) CEO Christopher von Jako on Q4 2019 Results - Earnings Call Transcript

Brainsway Ltd. (BWAY) Q4 2019 Earnings Conference Call March 23, 2020 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Christopher von Jako - CEO Hadar Levy - COO and CFO Conference Call Participants Craig Bijou - Cantor Fitzgerald Jayson Bedford - Raymond Ja...

BWAY - Brainsway EPS beats by $0.02, beats on revenue

Brainsway (NASDAQ: BWAY ): Q4 GAAP EPS of -$0.10 beats by $0.02 . More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

Previous 10 Next 10